These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34662186)

  • 1. Antifungal Therapy with Azoles Induced the Syndrome of Acquired Apparent Mineralocorticoid Excess: a Literature and Database Analysis.
    Ji HH; Tang XW; Zhang N; Huo BN; Liu Y; Song L; Jia YT
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0166821. PubMed ID: 34662186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of posaconazole- and itraconazole-induced pseudohyperaldosteronism and assessment of other systemically used azole antifungals.
    Beck KR; Telisman L; van Koppen CJ; Thompson GR; Odermatt A
    J Steroid Biochem Mol Biol; 2020 May; 199():105605. PubMed ID: 31982514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal therapy with azoles and the syndrome of acquired mineralocorticoid excess.
    Beck KR; Odermatt A
    Mol Cell Endocrinol; 2021 Mar; 524():111168. PubMed ID: 33484741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species-specific differences in the inhibition of 11β-hydroxysteroid dehydrogenase 2 by itraconazole and posaconazole.
    Inderbinen SG; Zogg M; Kley M; Smieško M; Odermatt A
    Toxicol Appl Pharmacol; 2021 Feb; 412():115387. PubMed ID: 33387577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating cardiac disorders associated with triazole antifungal agents based on the US Food and Drug Administration Adverse Event reporting system database.
    Chen J; Xu S; Yu W; Sun C; Zhang W
    Front Pharmacol; 2024; 15():1255918. PubMed ID: 38584605
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Thompson GR; Chang D; Wittenberg RR; McHardy I; Semrad A
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of triazole antifungals: a pharmacovigilance study from 2004 to 2021 based on FAERS.
    Chai S; Zhan JL; Zhao LM; Liu XD
    Ther Adv Drug Saf; 2022; 13():20420986221143266. PubMed ID: 36545565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.
    Hazirolan G; Canton E; Sahin S; Arikan-Akdagli S
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4841-7. PubMed ID: 23877683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database.
    Zhou ZX; Yin XD; Zhang Y; Shao QH; Mao XY; Hu WJ; Shen YL; Zhao B; Li ZL
    Front Pharmacol; 2022; 13():891336. PubMed ID: 35571077
    [No Abstract]   [Full Text] [Related]  

  • 11. Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
    Döring M; Eikemeier M; Cabanillas Stanchi KM; Hartmann U; Ebinger M; Schwarze CP; Schulz A; Handgretinger R; Müller I
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1189-200. PubMed ID: 25680318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse interactions between antifungal azoles and vincristine: review and analysis of cases.
    Moriyama B; Henning SA; Leung J; Falade-Nwulia O; Jarosinski P; Penzak SR; Walsh TJ
    Mycoses; 2012 Jul; 55(4):290-7. PubMed ID: 22126626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reference laboratory experience of clinically achievable voriconazole, posaconazole, and itraconazole concentrations within the bloodstream and cerebral spinal fluid.
    Wiederhold NP; Pennick GJ; Dorsey SA; Furmaga W; Lewis JS; Patterson TF; Sutton DA; Fothergill AW
    Antimicrob Agents Chemother; 2014; 58(1):424-31. PubMed ID: 24189246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation.
    Döring M; Blume O; Haufe S; Hartmann U; Kimmig A; Schwarze CP; Lang P; Handgretinger R; Müller I
    Eur J Clin Microbiol Infect Dis; 2014 Apr; 33(4):629-38. PubMed ID: 24173819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Analysis of Fluconazole, Isavuconazole, Itraconazole, Hydroxy-Itraconazole, Posaconazole, and Voriconazole in Human Plasma and Serum.
    Müller C; Gehlen D; Blaich C; Prozeller D; Liss B; Streichert T; Wiesen MHJ
    Ther Drug Monit; 2017 Oct; 39(5):505-513. PubMed ID: 28742650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin Allergy to Azole Antifungal Agents for Systemic Use: A Review of the Literature.
    Calogiuri G; Garvey LH; Nettis E; Romita P; Di Leo E; Caruso R; Butani L; Foti C
    Recent Pat Inflamm Allergy Drug Discov; 2019; 13(2):144-157. PubMed ID: 31538908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posaconazole-Induced Pseudohyperaldosteronism.
    Kuriakose K; Nesbitt WJ; Greene M; Harris B
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530850
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Sun Y; Tan L; Yao Z; Gao L; Yang J; Zeng T
    Microbiol Spectr; 2022 Feb; 10(1):e0200721. PubMed ID: 35019705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in immunosuppressant dose requirement when transitioning to isavuconazole from other azoles in thoracic transplant recipients.
    Kozuch JM; Burt C; Afshar K; Aslam S; Yung G; Mariski M; Golts E; Feist A
    Transpl Infect Dis; 2024 Feb; 26(1):e14209. PubMed ID: 38059638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azole antifungals: 35 years of invasive fungal infection management.
    Allen D; Wilson D; Drew R; Perfect J
    Expert Rev Anti Infect Ther; 2015 Jun; 13(6):787-98. PubMed ID: 25843556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.